InBody Co.Ltd (041830) - Total Liabilities

Latest as of September 2025: ₩36.31 Billion KRW ≈ $24.61 Million USD

Based on the latest financial reports, InBody Co.Ltd (041830) has total liabilities worth ₩36.31 Billion KRW (≈ $24.61 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how much of InBody Co.Ltd's assets are long-term investments to see how much of total assets are deployed in long-term investments.

InBody Co.Ltd - Total Liabilities Trend (2011–2024)

This chart illustrates how InBody Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see total assets of InBody Co.Ltd.

InBody Co.Ltd Competitors by Total Liabilities

The table below lists competitors of InBody Co.Ltd ranked by their total liabilities.

Company Country Total Liabilities
Ambassador Hotel Ltd
TW:2704
Taiwan NT$8.09 Billion
Wiscom System Co Ltd
SHE:002090
China CN¥1.45 Billion
Jinfa Labi Maternity & Baby Articles Co Ltd
SHE:002762
China CN¥146.19 Million
Elmera Group ASA
OL:ELMRA
Norway Nkr5.50 Billion
Allianz Ayudhya Capital Public Company Limited
BK:AYUD
Thailand ฿9.61 Billion
Hangzhou Landscape Architecture Design Institute Co Ltd
SHE:300649
China CN¥402.17 Million
Betterware de México, S.A.P.I. de C.V.
NASDAQ:BWMX
USA $8.81 Billion
TA-I Technology Co Ltd
TW:2478
Taiwan NT$3.02 Billion

Liability Composition Analysis (2011–2024)

This chart breaks down InBody Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is InBody Co.Ltd's balance sheet to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 6.17 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.13 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.11 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how InBody Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for InBody Co.Ltd (2011–2024)

The table below shows the annual total liabilities of InBody Co.Ltd from 2011 to 2024.

Year Total Liabilities Change
2024-12-31 ₩31.91 Billion
≈ $21.63 Million
+29.61%
2023-12-31 ₩24.62 Billion
≈ $16.69 Million
-10.16%
2022-12-31 ₩27.41 Billion
≈ $18.57 Million
+36.85%
2021-12-31 ₩20.03 Billion
≈ $13.57 Million
+24.49%
2020-12-31 ₩16.09 Billion
≈ $10.90 Million
+5.75%
2019-12-31 ₩15.21 Billion
≈ $10.31 Million
+108.38%
2018-12-31 ₩7.30 Billion
≈ $4.95 Million
+31.58%
2017-12-31 ₩5.55 Billion
≈ $3.76 Million
+16.54%
2016-12-31 ₩4.76 Billion
≈ $3.23 Million
-23.37%
2015-12-31 ₩6.21 Billion
≈ $4.21 Million
+74.47%
2014-12-31 ₩3.56 Billion
≈ $2.41 Million
+68.39%
2013-12-31 ₩2.11 Billion
≈ $1.43 Million
+4.24%
2012-12-31 ₩2.03 Billion
≈ $1.37 Million
+19.02%
2011-12-31 ₩1.70 Billion
≈ $1.15 Million
--

About InBody Co.Ltd

KQ:041830 Korea Healthcare Equipment & Supplies
Market Cap
$530.86 Million
₩783.34 Billion KRW
Market Cap Rank
#12012 Global
#328 in Korea
Share Price
₩58100.00
Change (1 day)
+0.52%
52-Week Range
₩26950.00 - ₩70800.00
All Time High
₩70800.00
About

InBody Co.,Ltd provides body composition analysis solutions worldwide. The company offers body composition analyzers, blood pressure monitors, stadiometers, and body water analyzers, as well as InBody dial and bands. Its products are used in nephrology, liver disease, diabetes, nutrition, and rehabilitation applications. The company was formerly known as Biospace Co., Ltd. InBody Co.,Ltd was foun… Read more